5 Key Takeaways
-
1
Home OCT monitoring for neovascular age-related macular degeneration offers reduced patient burden and continuous data collection.
-
2
The FDA approved the Scanly home OCT device in May 2024, enabling patients to perform scans at home.
-
3
Patients reported high satisfaction with the home OCT device, finding it user-friendly and reassuring.
-
4
The Wagner Kapoor Institute utilized its research wing to effectively implement the home OCT program.
-
5
Remote monitoring can enhance patient care, especially in rural areas, by detecting changes before symptoms arise.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.